Copyright Reports & Markets. All rights reserved.

Global Dermatophytic Onychomycosis Market Professional Survey Report 2019

Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Dermatophytic Onychomycosis

      • 1.1 Definition of Dermatophytic Onychomycosis
      • 1.2 Dermatophytic Onychomycosis Segment by Type
        • 1.2.1 Global Dermatophytic Onychomycosis Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Oral
        • 1.2.3 Topical
      • 1.3 Dermatophytic Onychomycosis Segment by Applications
        • 1.3.1 Global Dermatophytic Onychomycosis Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hospitals
        • 1.3.3 Clinics and laboratories
        • 1.3.4 Others
      • 1.4 Global Dermatophytic Onychomycosis Overall Market
        • 1.4.1 Global Dermatophytic Onychomycosis Revenue (2014-2025)
        • 1.4.2 Global Dermatophytic Onychomycosis Production (2014-2025)
        • 1.4.3 North America Dermatophytic Onychomycosis Status and Prospect (2014-2025)
        • 1.4.4 Europe Dermatophytic Onychomycosis Status and Prospect (2014-2025)
        • 1.4.5 China Dermatophytic Onychomycosis Status and Prospect (2014-2025)
        • 1.4.6 Japan Dermatophytic Onychomycosis Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Dermatophytic Onychomycosis Status and Prospect (2014-2025)
        • 1.4.8 India Dermatophytic Onychomycosis Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Dermatophytic Onychomycosis
      • 2.3 Manufacturing Process Analysis of Dermatophytic Onychomycosis
      • 2.4 Industry Chain Structure of Dermatophytic Onychomycosis

      3 Development and Manufacturing Plants Analysis of Dermatophytic Onychomycosis

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Dermatophytic Onychomycosis Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Dermatophytic Onychomycosis
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Dermatophytic Onychomycosis Production and Capacity Analysis
      • 4.2 Dermatophytic Onychomycosis Revenue Analysis
      • 4.3 Dermatophytic Onychomycosis Price Analysis
      • 4.4 Market Concentration Degree

      5 Dermatophytic Onychomycosis Regional Market Analysis

      • 5.1 Dermatophytic Onychomycosis Production by Regions
        • 5.1.1 Global Dermatophytic Onychomycosis Production by Regions
        • 5.1.2 Global Dermatophytic Onychomycosis Revenue by Regions
      • 5.2 Dermatophytic Onychomycosis Consumption by Regions
      • 5.3 North America Dermatophytic Onychomycosis Market Analysis
        • 5.3.1 North America Dermatophytic Onychomycosis Production
        • 5.3.2 North America Dermatophytic Onychomycosis Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Dermatophytic Onychomycosis Import and Export
      • 5.4 Europe Dermatophytic Onychomycosis Market Analysis
        • 5.4.1 Europe Dermatophytic Onychomycosis Production
        • 5.4.2 Europe Dermatophytic Onychomycosis Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Dermatophytic Onychomycosis Import and Export
      • 5.5 China Dermatophytic Onychomycosis Market Analysis
        • 5.5.1 China Dermatophytic Onychomycosis Production
        • 5.5.2 China Dermatophytic Onychomycosis Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Dermatophytic Onychomycosis Import and Export
      • 5.6 Japan Dermatophytic Onychomycosis Market Analysis
        • 5.6.1 Japan Dermatophytic Onychomycosis Production
        • 5.6.2 Japan Dermatophytic Onychomycosis Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Dermatophytic Onychomycosis Import and Export
      • 5.7 Southeast Asia Dermatophytic Onychomycosis Market Analysis
        • 5.7.1 Southeast Asia Dermatophytic Onychomycosis Production
        • 5.7.2 Southeast Asia Dermatophytic Onychomycosis Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Dermatophytic Onychomycosis Import and Export
      • 5.8 India Dermatophytic Onychomycosis Market Analysis
        • 5.8.1 India Dermatophytic Onychomycosis Production
        • 5.8.2 India Dermatophytic Onychomycosis Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Dermatophytic Onychomycosis Import and Export

      6 Dermatophytic Onychomycosis Segment Market Analysis (by Type)

      • 6.1 Global Dermatophytic Onychomycosis Production by Type
      • 6.2 Global Dermatophytic Onychomycosis Revenue by Type
      • 6.3 Dermatophytic Onychomycosis Price by Type

      7 Dermatophytic Onychomycosis Segment Market Analysis (by Application)

      • 7.1 Global Dermatophytic Onychomycosis Consumption by Application
      • 7.2 Global Dermatophytic Onychomycosis Consumption Market Share by Application (2014-2019)

      8 Dermatophytic Onychomycosis Major Manufacturers Analysis

      • 8.1 Anacor Pharmaceuticals
        • 8.1.1 Anacor Pharmaceuticals Dermatophytic Onychomycosis Production Sites and Area Served
        • 8.1.2 Anacor Pharmaceuticals Product Introduction, Application and Specification
        • 8.1.3 Anacor Pharmaceuticals Dermatophytic Onychomycosis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Galderma
        • 8.2.1 Galderma Dermatophytic Onychomycosis Production Sites and Area Served
        • 8.2.2 Galderma Product Introduction, Application and Specification
        • 8.2.3 Galderma Dermatophytic Onychomycosis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Janssen Biotech
        • 8.3.1 Janssen Biotech Dermatophytic Onychomycosis Production Sites and Area Served
        • 8.3.2 Janssen Biotech Product Introduction, Application and Specification
        • 8.3.3 Janssen Biotech Dermatophytic Onychomycosis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Novartis
        • 8.4.1 Novartis Dermatophytic Onychomycosis Production Sites and Area Served
        • 8.4.2 Novartis Product Introduction, Application and Specification
        • 8.4.3 Novartis Dermatophytic Onychomycosis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Valeant Pharmaceuticals
        • 8.5.1 Valeant Pharmaceuticals Dermatophytic Onychomycosis Production Sites and Area Served
        • 8.5.2 Valeant Pharmaceuticals Product Introduction, Application and Specification
        • 8.5.3 Valeant Pharmaceuticals Dermatophytic Onychomycosis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Abeona Therapeutics
        • 8.6.1 Abeona Therapeutics Dermatophytic Onychomycosis Production Sites and Area Served
        • 8.6.2 Abeona Therapeutics Product Introduction, Application and Specification
        • 8.6.3 Abeona Therapeutics Dermatophytic Onychomycosis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Allergan
        • 8.7.1 Allergan Dermatophytic Onychomycosis Production Sites and Area Served
        • 8.7.2 Allergan Product Introduction, Application and Specification
        • 8.7.3 Allergan Dermatophytic Onychomycosis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Elorac
        • 8.8.1 Elorac Dermatophytic Onychomycosis Production Sites and Area Served
        • 8.8.2 Elorac Product Introduction, Application and Specification
        • 8.8.3 Elorac Dermatophytic Onychomycosis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 GlaxoSmithKline
        • 8.9.1 GlaxoSmithKline Dermatophytic Onychomycosis Production Sites and Area Served
        • 8.9.2 GlaxoSmithKline Product Introduction, Application and Specification
        • 8.9.3 GlaxoSmithKline Dermatophytic Onychomycosis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Hexima
        • 8.10.1 Hexima Dermatophytic Onychomycosis Production Sites and Area Served
        • 8.10.2 Hexima Product Introduction, Application and Specification
        • 8.10.3 Hexima Dermatophytic Onychomycosis Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Hisamitsu Pharmaceutical
      • 8.12 Mayne Pharma
      • 8.13 MediQuest Therapeutics
      • 8.14 Meiji Seika Pharma
      • 8.15 Merz Pharma
      • 8.16 Moberg Pharma
      • 8.17 NanoBio
      • 8.18 NovaBiotics
      • 8.19 Nuvo Research
      • 8.20 Pfizer
      • 8.21 Polichem
      • 8.22 Promius Pharma
      • 8.23 Sanofi
      • 8.24 Seren Pharmaceuticals
      • 8.25 Taro Pharmaceutical
      • 8.26 Topica Pharmaceuticals
      • 8.27 Viamet Pharmaceuticals

      9 Development Trend of Analysis of Dermatophytic Onychomycosis Market

      • 9.1 Global Dermatophytic Onychomycosis Market Trend Analysis
        • 9.1.1 Global Dermatophytic Onychomycosis Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Dermatophytic Onychomycosis Regional Market Trend
        • 9.2.1 North America Dermatophytic Onychomycosis Forecast 2019-2025
        • 9.2.2 Europe Dermatophytic Onychomycosis Forecast 2019-2025
        • 9.2.3 China Dermatophytic Onychomycosis Forecast 2019-2025
        • 9.2.4 Japan Dermatophytic Onychomycosis Forecast 2019-2025
        • 9.2.5 Southeast Asia Dermatophytic Onychomycosis Forecast 2019-2025
        • 9.2.6 India Dermatophytic Onychomycosis Forecast 2019-2025
      • 9.3 Dermatophytic Onychomycosis Market Trend (Product Type)
      • 9.4 Dermatophytic Onychomycosis Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Dermatophytic Onychomycosis Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Dermatophytic onychomycosis is a fungal infection of the nail plate, nail bed, and, in some cases, the skin surrounding the nail plate. It is caused by yeast, dermatophytes, and molds; dermatophytes account for 90% of all cases. The fungus, especially Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum, infects the skin, hair, or nails. It is often perceived by people to be an active and contagious infection. Onychomycosis may persist or worsen if not treated. The fungi that cause onychomycosis exist in common sites such as floors, soil, socks, and shoes. Therapies for onychomycosis include debridement and drugs. Debridement is time consuming and minimally effective in eradicating the fungal infection. Systemic drug treatment is most effective in treating onychomycosis.
        Factors such as the rising prevalence of dermatophytic onychomycosis, heavy investments to develop therapies, and frequent product innovations will aid in the steady growth of this market during the forecast period. An important factor that will impel the prospects for growth in this market is the augmented focus on combination therapies. Recently, it has been observed that a combination of topical and systemic treatment increases the cure rate when compared to individual therapies. Since combination therapies have improved clinical efficiency and are more cost-effective than terbinafine, they are increasingly being preferred over individual terbinafine-based therapies as they have a higher cure rate.
        The global dermatophytic onychomycosis market is intensely competitive owing to the presence of numerous small and large vendors that operate at a local or global scale. To survive and succeed in this market, the vendors enter into strategic alliances with smaller players to manufacture and market new drugs.
        The Americas dominated this market and is envisaged to retain its dominating market position by the end of 2020 owing to the presence of a well-developed healthcare system

        The global Dermatophytic Onychomycosis market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Dermatophytic Onychomycosis volume and value at global level, regional level and company level. From a global perspective, this report represents overall Dermatophytic Onychomycosis market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Dermatophytic Onychomycosis in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Dermatophytic Onychomycosis manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Anacor Pharmaceuticals
        Galderma
        Janssen Biotech
        Novartis
        Valeant Pharmaceuticals
        Abeona Therapeutics
        Allergan
        Elorac
        GlaxoSmithKline
        Hexima
        Hisamitsu Pharmaceutical
        Mayne Pharma
        MediQuest Therapeutics
        Meiji Seika Pharma
        Merz Pharma
        Moberg Pharma
        NanoBio
        NovaBiotics
        Nuvo Research
        Pfizer
        Polichem
        Promius Pharma
        Sanofi
        Seren Pharmaceuticals
        Taro Pharmaceutical
        Topica Pharmaceuticals
        Viamet Pharmaceuticals

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Oral
        Topical

        Segment by Application
        Hospitals
        Clinics and laboratories
        Others

        Buy now